[No role for oral anticoagulants (target INR; 2.0-3.0) after transient ischaemic attack or cerebral infarction of arterial origin; the European/Australasian stroke prevention in reversible ischaemia trial (ESPRIT).]

E.L.L.M. de Schryver; P.H.A. Halkes; A. Algra

[No role for oral anticoagulants (target INR; 2.0-3.0) after transient ischaemic attack or cerebral infarction of arterial origin; the European/Australasian stroke prevention in reversible ischaemia trial (ESPRIT).]

Translated title of the contribution: [No role for oral anticoagulants (target INR; 2.0-3.0) after transient ischaemic attack or cerebral infarction of arterial origin; the European/Australasian stroke prevention in reversible ischaemia trial (ESPRIT).]

E.L.L.M. de Schryver, P.H.A. Halkes, A. Algra

Research output: Contribution to journal › Article › Professional

Translated title of the contribution	[No role for oral anticoagulants (target INR; 2.0-3.0) after transient ischaemic attack or cerebral infarction of arterial origin; the European/Australasian stroke prevention in reversible ischaemia trial (ESPRIT).]
Original language	Undefined/Unknown
Pages (from-to)	445-453
Number of pages	9
Journal	Nederlands Tijdschrift voor Geneeskunde
Volume	152
Issue number	8
Publication status	Published - 2008

Cite this

@article{768238b6a1f24a8ab21c31593133ccd2,

title = "[No role for oral anticoagulants (target INR; 2.0-3.0) after transient ischaemic attack or cerebral infarction of arterial origin; the European/Australasian stroke prevention in reversible ischaemia trial (ESPRIT).]",

author = "{de Schryver}, E.L.L.M. and P.H.A. Halkes and A. Algra",

year = "2008",

language = "Undefined/Unknown",

volume = "152",

pages = "445--453",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",

publisher = "Bohn Stafleu van Loghum",

number = "8",

}

[No role for oral anticoagulants (target INR; 2.0-3.0) after transient ischaemic attack or cerebral infarction of arterial origin; the European/Australasian stroke prevention in reversible ischaemia trial (ESPRIT).]. / de Schryver, E.L.L.M.; Halkes, P.H.A.; Algra, A.
In: Nederlands Tijdschrift voor Geneeskunde, Vol. 152, No. 8, 2008, p. 445-453.

Research output: Contribution to journal › Article › Professional

TY - JOUR

T1 - [No role for oral anticoagulants (target INR; 2.0-3.0) after transient ischaemic attack or cerebral infarction of arterial origin; the European/Australasian stroke prevention in reversible ischaemia trial (ESPRIT).]

AU - de Schryver, E.L.L.M.

AU - Halkes, P.H.A.

AU - Algra, A.

PY - 2008

Y1 - 2008

M3 - Article

SN - 0028-2162

VL - 152

SP - 445

EP - 453

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

IS - 8

ER -